Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tohru Izumi

Showing results (1-10 of 195) with videos related to

Pageof 20
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 15, 2014
[Novel targeted therapy in multiple myeloma]Tohru Izumi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 21, 2012
[Management of bone disease in multiple myeloma]Tohru Izumi
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 13, 2006
[ACE inhibitor]Hidehira Fukaya, Tohru Izumi
Circulation Journal : Official Journal of the Japanese Circulation Society|December 26, 2003
Cost-effectiveness analysis of carvedilol for the treatment of chronic heart failure in JapanTakayuki Inomata, Tohru Izumi, Makoto Kobayashi
Circulation Journal : Official Journal of the Japanese Circulation Society|February 27, 2007
Resveratrol ameliorates experimental autoimmune myocarditisYuki Yoshida, Tetsuo Shioi, Tohru Izumi
Circulation Journal : Official Journal of the Japanese Circulation Society|August 11, 2010
A national survey on myocarditis associated with the 2009 influenza A (H1N1) pandemic in JapanAkira Ukimura, Tohru Izumi, Akira Matsumori, et al.
Current Vascular Pharmacology|October 16, 2008
Beyond cholesterol lowering: pleiotropic effects of bile acid binding resins against cardiovascular disease risk factors in patients with metabolic syndromeMinako Yamaoka-Tojo, Taiki Tojo, Tohru Izumi
Internal Medicine (Tokyo, Japan)|February 14, 2003
Myocarditogenic epitopes and autoimmune myocarditisTohru Izumi, Ken Kohno, Takayuki Inomata, et al.
British Journal of Pharmacology|January 11, 2003
Bradykinin inhibits development of myocardial infarction through B2 receptor signalling by increment of regional blood flow around the ischaemic lesions in ratsHiroshi Ito, Izumi Hayashi, Tohru Izumi, et al.
Heart and Vessels|April 6, 2013
Efficacy and safety of bisoprolol fumarate compared with carvedilol in Japanese patients with chronic heart failure: results of the randomized, controlled, double-blind, Multistep Administration of bisoprolol IN Chronic Heart Failure II (MAIN-CHF II) studyMasatsugu Hori, Ryozo Nagai, Tohru Izumi, et al.
Pageof 20

Showing results (1-10 of 195) with videos related to

Sort By:
Pageof 20
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 15, 2014
[Novel targeted therapy in multiple myeloma]Tohru Izumi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 21, 2012
[Management of bone disease in multiple myeloma]Tohru Izumi
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 13, 2006
[ACE inhibitor]Hidehira Fukaya, Tohru Izumi
Circulation Journal : Official Journal of the Japanese Circulation Society|December 26, 2003
Cost-effectiveness analysis of carvedilol for the treatment of chronic heart failure in JapanTakayuki Inomata, Tohru Izumi, Makoto Kobayashi
Circulation Journal : Official Journal of the Japanese Circulation Society|February 27, 2007
Resveratrol ameliorates experimental autoimmune myocarditisYuki Yoshida, Tetsuo Shioi, Tohru Izumi
Circulation Journal : Official Journal of the Japanese Circulation Society|August 11, 2010
A national survey on myocarditis associated with the 2009 influenza A (H1N1) pandemic in JapanAkira Ukimura, Tohru Izumi, Akira Matsumori, et al.
Current Vascular Pharmacology|October 16, 2008
Beyond cholesterol lowering: pleiotropic effects of bile acid binding resins against cardiovascular disease risk factors in patients with metabolic syndromeMinako Yamaoka-Tojo, Taiki Tojo, Tohru Izumi
Internal Medicine (Tokyo, Japan)|February 14, 2003
Myocarditogenic epitopes and autoimmune myocarditisTohru Izumi, Ken Kohno, Takayuki Inomata, et al.
British Journal of Pharmacology|January 11, 2003
Bradykinin inhibits development of myocardial infarction through B2 receptor signalling by increment of regional blood flow around the ischaemic lesions in ratsHiroshi Ito, Izumi Hayashi, Tohru Izumi, et al.
Heart and Vessels|April 6, 2013
Efficacy and safety of bisoprolol fumarate compared with carvedilol in Japanese patients with chronic heart failure: results of the randomized, controlled, double-blind, Multistep Administration of bisoprolol IN Chronic Heart Failure II (MAIN-CHF II) studyMasatsugu Hori, Ryozo Nagai, Tohru Izumi, et al.
Pageof 20